PTPI实时信号 | 通过Getagraph.com最大化利润

出售 113167 min ago

@ $1.580

发出时间: 14 Feb 2024 @ 02:18

回报率: -58.42%

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 04:00):

Stats
今日成交量	142 751
平均成交量	792 383
市值	4.52M
EPS	$0 ( 2024-03-27 )
下一个收益日期	( $0 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.100
ATR14	$0.00500 (0.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-21	Bernstein Bruce	Buy	40 000	Stock Option (Right to Buy)
2023-12-21	Boctor Fady	Buy	54 533	Stock Option (Right to Buy)
2023-12-21	Boctor Fady	Buy	49 645	Common Stock
2023-12-21	Walker Wayne Remell	Buy	40 000	Stock Option (Right to Buy)
2023-12-21	Arnold Mitchell	Buy	20 000	Stock Option (Right to Buy)

INSIDER POWER
90.60
Last 73 transactions
Buy: 12 778 148 \| Sell: 66 349

音量相关性

長: -0.06 (neutral)

短: 0.14 (neutral)

Signal:(54.341) Neutral

Petros Pharmaceuticals, 相关性

10 最正相关
ALZN	0.942
AVO	0.941
AMTI	0.922
TCRT	0.913
LYRA	0.91
FATE	0.908
IMCC	0.908
LQDT	0.906
GH	0.905
BIMI	0.903

10 最负相关
BNIXU	-0.927
OPNT	-0.924
DVCR	-0.923
STAY	-0.919
AVEO	-0.911
ITMR	-0.907
CIIG	-0.906
VLYPP	-0.904
GLLI	-0.9
ISIG	-0.898

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Petros Pharmaceuticals, 相关性 - 货币/商品

0.03
( neutral )

-0.05
( neutral )

0.00
( neutral )

-0.20
( neutral )

Petros Pharmaceuticals, 财务报表

Annual	2023
营收:	$5.82M
毛利润:	$908 201 (15.60 %)
EPS:	$-3.75

FY	2023
营收:	$5.82M
毛利润:	$908 201 (15.60 %)
EPS:	$-3.75

FY	2022
营收:	$5.99M
毛利润:	$3.70M (61.79 %)
EPS:	$-13.06

FY	2021
营收:	$7.81M
毛利润:	$6.21M (79.52 %)
EPS:	$-1 682.68

Financial Reports:

No articles found.

Petros Pharmaceuticals,

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.